Evaluation of the content and the pathogenetic role of cytokines in the peritoneal fluid in patients with deep infiltrative endometriosis

Cover Page

Abstract


Background. Deep infiltrative endometriosis (DIE) is characterized by the invasion of endometriosis lesions in tissues and organs to a depth of over 5 mm. In recent years, the proportion of infiltrative forms of endometriosis has been steadily increasing. The main clinical manifestations is chronic pelvic pain syndrome and infertility. A key element in the pathogenesis of deep infiltrative endometriosis is an ineffective inflammatory response.

Objective. Evaluate the content and the role of pro- and anti-inflammatory cytokines, growth factors and chemokines in the pathogenesis of deep infiltrative endometriosis for pathogenetically grounded immunomodulatory therapy.

Materials and methods. The present study included 120 women with deep infiltrative endometriosis. In the peritoneal fluid, using IFA determined the level of IL-33, and with the help of running cytofluometry format NEA has estimated the levels of IL-2, IL-6, IL-10, IP-10, MCP-1 and growth factors – FGF, TGF-β.

Results. In the study of peritoneal fluid of patients with DIE was a significant decrease in the level of IL-2 and IL-10 6.7 times compared to the control group. The level of IL-6 was increased in 1.5 times, as well as the level of IL-33, and was awarded the data link cytokines with the severity of pain. DIE is characterized by increased levels of MCP-1 in 2 times and decrease in IP-10 1.3 times, as well as increased levels of FGF 1.5 times and reduced levels of TGF-β in 1.9 times in comparison with the control group.

Conclusion. For effective treatment of DIE and to increase the duration of recurrence-free period actual and pathogenetically justified is the inclusion of a combined treatment of immunomodulatory therapy with recombinant IL-2 aimed at the elimination of immunological disorders in the pelvic cavity.


Dmitry Z Tsitskarava

Author for correspondence.
tsitsskarava@yandex.ru
FSBSI “The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott”
Russian Federation

postgraduate student. Department of operative gynecology

Mariya I Yarmolinskaya

m.yarmolinskaya@gmail.com
FSBSI “The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott”
Russian Federation

professor of Russian Academy of Sciences, leading research assistant of department of endocrinology of reproduction, Doctor of medical sciences, head of center “Diagnostics and treatment of endometriosis”

Alexandr V Selutin

a_selutin@yahoo.com
FSBSI “The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott”
Russian Federation

PhD, laboratory of immunology

Sergey A Selkov

selkovsa@mail.ru
FSBSI “The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott”
Russian Federation

Doctor of medical sciences, professor, Head of laboratory of immunology

  • Ярмолинская М.И. Генитальный эндометриоз: влияние гормональных, иммунологических и генетических факторов на развитие, особенности течения и выбор терапии: автореф. дис. … д-ра мед. наук. – СПб., 2009. [Jarmolinskaja MI. Genital’nyj jendometrioz: vlijanie gormonal’nyh, immunologicheskih i geneticheskih faktorov na razvitie, osobennosti techenija i vybor terapii [dissertation]. Saint Petersburg; 2009. (In Russ.)]
  • Сельков С.А., Ярмолинская М.И., Павлов О.В., и др. Системный и локальные уровни регуляции иммунопатогенетических процессов у пациенток с наружным генитальным эндометриозом // Журнал акушерства и женских болезней. – 2005. – № 1. – С. 20–28. [Sel’kov SA, Jarmolinskaja MI, Pavlov OV, et al. Sistemnyj i lokal’nye urovni reguljacii immunopatogeneticheskih processov u pacientok s naruzhnyj genital’nym jendometriozom. Journal of Obstetrics and Women’s Diseases. 2005;(1):20-28. (In Russ.)]
  • Соколов Д.И., Кондратьева П.Г., Розломий В.Л., и др. Роль ангиогенеза в развитии наружного генитального эндометриоза // Цитокины и воспаление. – 2007. – № 2. – С. 10–17. [Sokolov DI, Kondrat’eva PG, Rozlomij VL, et al. Rol’ angiogeneza v razvitii naruzhnogo genital’nogo jendometrioza. Citokiny i vospalenie. 2007;(2):10-17. (In Russ.)]
  • Кондратьева П.Г., Соколов Д.И., Селютин А.В., и др. Содержание хемокинов и провоспалительных цитокинов в перитонеальной жидкости больных наружным генитальным эндометриозом // Медицинская иммунология. – 2006. – № 2–3. – С. 311. [Kondrat’eva PG, Sokolov DI, Seljutin AV, et al. Soderzhanie hemokinov i provospalitel’nyh citokinov v peritoneal’noj zhidkosti bol’nyh naruzhnym genital’nym jendometriozom. Medicinskaja immunologija. 2006;(2-3):311. (In Russ.)]
  • Соколов Д.И., Солодовникова Н.Г., Павлов О.В., и др. Исследование цитокинового профиля и ангиогенного потенциала перитонеальной жидкости больных с наружным генитальным эндометриозом // Бюллетень экспериментальной биологии и медицины. – 2005. – № 11. – С. 552–555. [Sokolov DI, Solodovnikova NG, Pavlov OV, et al. Study of cytokine profile and angiogenic potential of peritoneal fluid in patients with external genital endometriosis. Bulletin of experimental biology and medicine. 2005;(11):552-555. (In Russ.)]
  • Солодовникова Н.Г., Павлов О.В., Сельков С.А. Исследование in vitro особенностей цитокинов при наружном генитальном эндометриозе // Медицинская иммунология. – 2004. – № 3–5. – С. 390. [Solodovnikova NG, Pavlov OV, Sel’kov SA. Issledovanie in vitro osobennostej citokinov pri naruzhnom genital’nom jendometrioze. Medicinskaja immunologija. 2004;(3-5):390. (In Russ.)]
  • Velasco I, Acien P, Campos A, et al. Interleukin-6 and other soluble factors in peritoneal fkuid and endometriomas and their relation to pain and aromatase expression. J Reprod Immunol. 2010;84(2):199-205. doi: 10.1016/j.jri.2009.11.004. Epub 2010 Jan 13.
  • Ярмолинская М.И., Селютин А.В., Денисова В.М., и др. Роль иммунного ответа TH1/TH2 у больных с наружным генитальным эндометриозом // Российский иммунологический журнал. – 2008. – Т. 2. – № 2–3. – С. 302. [Jarmolinskaja MI, Seljutin AV, Denisova VM, et al. Rol’ immunnogo otveta TH1/TH2 u bol’nyh s naruzhnym genital’nym jendometriozom. Rossijskij immunologicheskij zhurnal. 2008;(2-3):302. (In Russ.)]
  • Vercellini P, Somigliana E, Vigano P, et al. Chronic pelvic pain in women: etiology, pathogenesis and diagnostic approach. Gynecol Endocrinol. 2009;25(3):149-158. doi: 10.1080/09513590802549858.
  • Fauconnier A, Fritel X, Chapron C. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Gynecol Obstet Fertil. 2009;37(1):57-69. doi: 10.1016/j.gyobfe.2008.08.016.
  • Rapkin A, Morgan M, Bonpane C, Martinez-Maza O. Peritoneal fluid interleukin-6 in women with chronic pelvic pain. Fertil Steril. 2000 Aug;74(2):325-8. doi: 10.1016/S0015-0282(00)00653-1.
  • Punnonen J, Teisala K, Ranta H, et al. Increased levels of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis. Am J Obstet Gynecol. 1996;174(5):1522-26. doi: 10.1016/S0002-9378(96)70600-2.
  • Mei J, Xie XX, Li MQ, et al. Indoleamine 2,3-dioxygenase-1 (IDO1) in human endometrial stromal cells induces macrophage tolerance through interleukin-33 in the progression of endometriosis. Int J Clin Exp Pathol. 2014;7(6):2743-53.
  • Кетлинский С.А., Симбирцев А.С. Цитокины. – СПб.: Фолиант, 2008. [Ketlinskij SA, Simbircev AS. Citokiny. Saint Petersburg: Foliant; 2008. (In Russ.)]
  • Arici A, Oral E, Attar E, et al. Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and itsmodulation of expression in mesothelial cells. Fertil Steril. 1997;67(6):1065-72. doi: 10.1016/S0015-0282(97)81440-9.
  • Saito A, Osuga Y, Yoshino O, et al. TGF-β1 induces proteinase-activated receptor 2 (PAR2) expression in endometriotic stromal cells and stimulates PAR2 activation-induced secretion of IL-6. Hum Reprod. 2011;26(7):1892-8. doi: 10.1093/humrep/der125. Epub 2011 May 5.
  • Павлов Р.В., Сельков С.А., Аксененко Д.В. Применение ронколейкина в противорецидивной терапии наружного генитального эндометриоза // Российский иммунологический журнал. – 2008. – № 2–3. – С. 294. [Pavlov RV, Sel’kov SA, Aksenenko DV. Primenenie Ronkolejkina v protivorecidivnoj terapii naruzhnogo genital’nogo jendometrioza. Rossijskij immunologicheskij zhurnal. 2008;(2-3):294. (In Russ.)]

Views

Abstract - 30

PDF (Russian) - 29


Copyright (c) 2017 ECO-vector LLC

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.